Li Kang Biomedical Stock Cash Flow From Operations
| 6242 Stock | TWD 52.30 0.40 0.76% |
Li Kang Biomedical fundamentals help investors to digest information that contributes to Li Kang's financial success or failures. It also enables traders to predict the movement of 6242 Stock. The fundamental analysis module provides a way to measure Li Kang's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Li Kang stock.
6242 |
Li Kang Biomedical Company Cash Flow From Operations Analysis
Li Kang's Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current Li Kang Cash Flow From Operations | 60.45 M |
Most of Li Kang's fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Li Kang Biomedical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
| Competition |
In accordance with the recently published financial statements, Li Kang Biomedical has 60.45 M in Cash Flow From Operations. This is 91.63% lower than that of the Personal Products sector and significantly higher than that of the Consumer Staples industry. The cash flow from operations for all Taiwan stocks is 93.78% higher than that of the company.
6242 Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Li Kang's direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Li Kang could also be used in its relative valuation, which is a method of valuing Li Kang by comparing valuation metrics of similar companies.Li Kang is currently under evaluation in cash flow from operations category among related companies.
6242 Fundamentals
| Return On Equity | 0.19 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.16 % | |||
| Operating Margin | 0.19 % | |||
| Current Valuation | 1.05 B | |||
| Shares Outstanding | 23.31 M | |||
| Shares Owned By Insiders | 72.30 % | |||
| Price To Earning | 15.32 X | |||
| Price To Book | 2.30 X | |||
| Price To Sales | 1.94 X | |||
| Revenue | 386.97 M | |||
| Gross Profit | 264.68 M | |||
| EBITDA | 76.83 M | |||
| Net Income | 51.44 M | |||
| Cash And Equivalents | 187.44 M | |||
| Cash Per Share | 8.04 X | |||
| Total Debt | 24.59 M | |||
| Debt To Equity | 0.06 % | |||
| Current Ratio | 2.56 X | |||
| Book Value Per Share | 23.12 X | |||
| Cash Flow From Operations | 60.45 M | |||
| Earnings Per Share | 4.16 X | |||
| Number Of Employees | 123 | |||
| Beta | 0.47 | |||
| Market Capitalization | 1.37 B | |||
| Total Asset | 616.07 M | |||
| Z Score | 33.0 | |||
| Annual Yield | 0.03 % | |||
| Net Asset | 616.07 M | |||
| Last Dividend Paid | 1.43 |
About Li Kang Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Li Kang Biomedical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Li Kang using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Li Kang Biomedical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Li Kang Biomedical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Money Flow Index module to determine momentum by analyzing Money Flow Index and other technical indicators.
Complementary Tools for 6242 Stock analysis
When running Li Kang's price analysis, check to measure Li Kang's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Li Kang is operating at the current time. Most of Li Kang's value examination focuses on studying past and present price action to predict the probability of Li Kang's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Li Kang's price. Additionally, you may evaluate how the addition of Li Kang to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |